ATF6 and fatty liver disease: First, in this study, we demonstrated that GYY4137, the H2S releasing agent, ameliorated the glucose intolerance and lipid metabolism abnormalities on ATF6−/− mice fed with HFD, suggesting that ATF6 attenuates hepatic steatosis in fatty liver by inducing H2S accumulation.